Detalhe da pesquisa
1.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34904799
2.
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia.
Br J Haematol
; 2024 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38639192
3.
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38504454
4.
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3.
Eur J Haematol
; 112(3): 475-478, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37918825
5.
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Blood
; 137(7): 877-887, 2021 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33181832
6.
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood
; 137(25): 3495-3506, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33598678
7.
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia.
Future Oncol
; 19(5): 345-353, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36815271
8.
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.
Eur J Haematol
; 109(6): 719-727, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36048142
9.
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism.
Nucleic Acids Res
; 48(22): 12727-12745, 2020 12 16.
Artigo
Inglês
| MEDLINE | ID: mdl-33245769
10.
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
N Engl J Med
; 378(25): 2399-2410, 2018 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29856685
11.
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Ann Hematol
; 100(4): 987-993, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33495922
12.
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil.
Blood
; 132(1): 9-16, 2018 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29720488
13.
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.
Blood
; 131(17): 1955-1959, 2018 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29437588
14.
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
Am J Hematol
; 95(5): 510-520, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32052473
15.
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
Br J Haematol
; 187(3): 319-327, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31218679
16.
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.
Blood
; 129(18): 2471-2478, 2017 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28270452
17.
Cytogenetic landscape in 1012 newly diagnosed chronic lymphocytic leukemia.
Eur J Haematol
; 103(6): 607-613, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31512291
18.
Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL.
Br J Haematol
; 202(2): 217-218, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37013670
19.
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.
Am J Hematol
; 2018 Jun 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29884994
20.
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Am J Hematol
; 93(6): 729-735, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29473209